Paradigm Biopharmaceuticals Limited (PBIGF)

0.1669 0.0000 (0.00%) At close: 03:03PM EDT

Paradigm Biopharmaceuticals Limited

500 Collins Street
Level 15
Melbourne, VIC 3000
Australia
61 3 9629 5566
https://www.paradigmbiopharma.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Paul John Rennie BSc, Grad Dip, MBM, MSTC	Founder, MD & Executive Chairman	1.13M	N/A	1959
Dr. Donna L. Skerrett M.D., MS	Chief Medical Officer and Executive Director	810.85k	N/A	1957
Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A.	Interim Company Secretary & Interim CFO	N/A	N/A	N/A
Dr. Ravi Krishnan	Chief Scientific Officer	N/A	N/A	N/A
Mr. Simon White	Director of Investor Relations	N/A	N/A	N/A
Dr. Michael Imperiale	Global Head of Drug Safety & MPS	N/A	N/A	N/A
Ms. Beverley Huttmann	Commercial Head	N/A	N/A	N/A
Ms. Michelle Coffey	Global Head of Regulatory Affairs	N/A	N/A	N/A
Dr. Mukesh Ahuja	Global Clinical Head of OA	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.

Corporate governance

Paradigm Biopharmaceuticals Limited’s ISS governance QualityScore as of 1 April 2024 is 10. The pillar scores are Audit: 9; Board: 10; Shareholder rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.